Edith Hintermann

Frankfurt Am Main, HE 60590, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Sex-specific differences of amlexanox in a mouse model for atherosclerosis and MASLD.

Sex-specific differences of amlexanox in a mouse model for atherosclerosis and MASLD.

Journal: Molecular metabolism
Published: March 09, 2026

Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 Diabetes.

Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 Diabetes.

Journal: Molecular metabolism
Published: June 18, 2025

Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.

Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.

Journal: Journal of autoimmunity
Published: December 27, 2023

The XCL1/XCR1 axis is upregulated in type 1 diabetes and aggravates its pathogenesis.

The XCL1/XCR1 axis is upregulated in type 1 diabetes and aggravates its pathogenesis.

Journal: JCI insight
Published: December 26, 2023

Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.

Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes.

Journal: Journal of autoimmunity
Published: October 03, 2023

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in mice.

Journal: EBioMedicine
Published: September 14, 2023

Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes.

Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes.

Journal: Clinical and experimental immunology
Published: May 25, 2023

Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement.

Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement.

Journal: Frontiers in physiology
Published: April 19, 2022

Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?

Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?

Journal: Frontiers in immunology
Published: March 17, 2022

Interleukin-22 in acute-on-chronic liver failure: A matter of ineffective levels, receptor dysregulation or defective signalling?

Interleukin-22 in acute-on-chronic liver failure: A matter of ineffective levels, receptor dysregulation or defective signalling?

Journal: Journal of hepatology
Published: April 20, 2020

The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis.

The Many Roles of Cell Adhesion Molecules in Hepatic Fibrosis.

Journal: Cells
Published: October 30, 2019

Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model.

Dexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model.

Journal: ACS nano
Published: March 19, 2019
Showing 1-12 of 31

Last Updated: 09/26/2026